Search in:

Pragmatic and Observational Research Volume 9, 2018 - Issue

Submit an article Journal homepage

Open access

118

Views

CrossRef citations to date

Altmetric

Original Research

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset

Sabrina Mueller1 Institute for Pharmacoeconomics and Medication Logistics, University of Wismar, Wismar, GermanyCorrespondence[email protected]

Antje Groth1 Institute for Pharmacoeconomics and Medication Logistics, University of Wismar, Wismar, Germany

Stefan G Spitzer2 Praxisklinik Herz und Gefäße Dresden, Academic Educational Practice Clinic, TU Dresden, Dresden, Germany;3 Institute of Medical Technology, Brandenburg University of Technology Cottbus–Senftenberg, Senftenberg, Germany

Anja Schramm4 AOK Bayern, Regensburg, Germany

Andreas Pfaff5 AOK Baden-Württemberg, Stuttgart, Germany

Ulf Maywald6 AOK PLUS, Dresden, Germany

Pages 1-10 | Published online: 01 May 2018

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (15)

Lisette Warkentin, Florian Klohn, Barthold Deiters, Thomas Kühlein & Susann Hueber. (2023) Vitamin-K-antagonist phenprocoumon versus direct oral anticoagulants in patients with atrial fibrillation: a real-world analysis of German claims data. BMJ Open 13:1, pages e063490.
Crossref

Gerhard F. Hamann, D. Sander, Armin Grau & J. Röther. (2022) S2k-Leitlinie: Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke (TIA) – Teil 1 und Teil 2S2k guideline: secondary prevention of ischemic stroke and transitory ischemic attack—part 1 and part 2. DGNeurologie 5:5, pages 369-380.
Crossref

Lisette Warkentin, Susann Hueber, Barthold Deiters, Florian Klohn & Thomas Kühlein. (2022) Vitamin-K-antagonist phenprocoumon versus low-dose direct oral anticoagulants (DOACs) in patients with atrial fibrillation: a real-world analysis of German claims data. Thrombosis Journal 20:1.
Crossref

Hans-Otto Wagner. 2022. Facharzt Allgemeinmedizin. Facharzt Allgemeinmedizin 813 820 .

Gianluca Grimaldi, Domenica Ancona, Domenico Tricarico, Paolo Stella, Cataldo Procacci, Antonio Germinario, Vito Bavaro, Vito Montanaro & Alessandro Delle Donne. (2021) Analysis of the Introduction in Clinical Practice of New Oral Anticoagulants in Local Health Agency BT: Translation of the Clinical Trial Data to a Local Health Care Area. Pharmaceutics 13:2, pages 252.
Crossref

Lena M. Paschke, Kerstin Klimke, Attila Altiner, Dominik von Stillfried & Maike Schulz. (2020) Comparing stroke prevention therapy of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: a nationwide retrospective observational study. BMC Medicine 18:1.
Crossref

Katrin Krueger, Kathrin Jobski, Annemarie Voss & Ulrike Haug. (2020) Different Risk Profiles of European Patients Using Direct Oral Anticoagulants or Vitamin K Antagonists: a Rapid Review. Current Epidemiology Reports 7:4, pages 290-299.
Crossref

S. R. Gilyarevsky & Yu. N. Belenkov. (2020) Evidence-based approaches to comparing the effectiveness of modern cardiology interventions: trends, bias and prospects. Russian Journal of Cardiology 25:8, pages 4037.
Crossref

S. Knecht & T. Schmidt-Wilcke. (2020) Der zweite Blick: praktische diagnostische und therapeutische Checks in der rehabilitativen NeurologieSecond look: practical diagnostic and therapeutic checks in neurorehabilitation. Der Nervenarzt 91:4, pages 324-336.
Crossref

Lars J. Kjerpeseth, Randi Selmer, Inger Ariansen, Øystein Karlstad, Hanne Ellekjær & Eva Skovlund. (2019) Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study. PLOS ONE 14:8, pages e0221500.
Crossref

Roland Diel & Niklas Lampenius. (2019) Cost-benefit analysis of VKA versus NOAC treatment in German patients with atrial fibrillation utilizing patient self-testing. Journal of Health Economics and Outcomes Research, pages 142-159.
Crossref

John Robson, Rohini Mathur, Marian Priebe, Zaheer Ahmed & Luis Ayerbe. (2019) Thromboembolic and haemorrhagic events in patients with atrial fibrillation: a prospective cohort study in UK primary and secondary care. British Journal of General Practice 69:683, pages e407-e412.
Crossref

Hendrik Bonnemeier, Maria Huelsebeck & Sebastian Kloss. (2019) Comparative effectiveness of rivaroxaban versus a vitamin K antagonist in patients with renal impairment treated for non-valvular atrial fibrillation in Germany — A retrospective cohort study. IJC Heart & Vasculature 23, pages 100367.
Crossref

H. J. Heppner. (2018) Schlagen VKA die neuen DOAK in der Praxis?. MMW - Fortschritte der Medizin 160:16, pages 36-36.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset

Articles from other publishers (15)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset

Citations (15)

Articles from other publishers (15)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date